Document Detail


Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT Study.
MedLine Citation:
PMID:  23190794     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Antihypertensive therapy is aimed at improving vascular and cardiac health, as well as lowering blood pressure (BP). The benefit of such drugs in untreated patients with borderline BP has not been demonstrated. Subjects with BPs 130 mm Hg systolic or 85 mm Hg diastolic and at least one additional risk factor were randomly assigned to treatment with carvedilol, lisinopril, their combination or placebo. Cardiovascular health was assessed by a disease score (DS), which combines the following tests of cardiovascular function and structure: resting BP, large- and small-artery elasticity (SAE), BP response to exercise, retinal vasculature analysis, electrocardiogram, carotid intima-medial thickness, left ventricular mass, microalbuminuria and N-terminal pro B-type natriuretic peptide. DS was assessed at baseline, after 3 and 9 months of therapy and 1 month after discontinuation of therapy. All active treatment groups displayed a sustained reduction in BP during 9 months of treatment, with the greatest reduction in the cardvedilol+lisinopril group. DS and SAE improved in all the treatment groups but the changes were of borderline significance and exhibited no evidence for progressive improvement from 3 months (functional) to 9 months (structural). All changes were reversed within 1 month after discontinuation of therapy. We conclude that 9 months of treatment with carvedilol, lisinopril or their combination produce a sustained and well-tolerated functional improvement but not a structural improvement, perhaps because of a lack of the nitric oxide-enhancing effects of other agents that inhibit structural changes in the vasculature.Journal of Human Hypertension advance online publication, 29 November 2012; doi:10.1038/jhh.2012.54.
Authors:
S M Saul; D A Duprez; W Zhong; G A Grandits; J N Cohn
Related Documents :
1382264 - Disparate effects of calcium channel blockers on pressure dependence of renin secretion...
14567424 - Clinical comparison of three methods to measure blood pressure in nonsedated dogs.
23370164 - Aliskiren improves blood pressure control and prevents cardiac damage in high-risk hype...
2706754 - Hemodynamic effects of monophosphoryl lipid a compared to endotoxin.
16574924 - Reduced risk factors for vascular disorders in parkinson disease patients: a case-contr...
23571074 - Safety climate dimensions as predictors for risk behavior.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-29
Journal Detail:
Title:  Journal of human hypertension     Volume:  -     ISSN:  1476-5527     ISO Abbreviation:  J Hum Hypertens     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8811625     Medline TA:  J Hum Hypertens     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Cardiology Division, University of Minnesota Medical School, Minneapolis, MN, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The increased prevalence of left ventricular hypertrophy and concentric remodeling in U.K. Indian As...
Next Document:  Role of alkyl chain branching on aggregation behavior of two symmetrical diglycolamides: Small angle...